8-K: Lifecore Biomedical Appoints Ryan Lake as New CFO Following Morberg's Departure

Lifecore Biomedical has appointed Ryan Lake as its new Chief Financial Officer, effective September 3, 2024, succeeding John Morberg who is stepping down.

Summary

• Lifecore Biomedical has announced the appointment of Ryan D. Lake as its new Chief Financial Officer and Secretary, effective September 3, 2024.
• The current CFO, John D. Morberg, will be stepping down on September 2, 2024, with his departure treated as a termination by the company without cause subsequent to a change in control.
• Ryan Lake brings extensive experience in the CDMO industry, having previously served as CFO of Societal CDMO, Inc., and has a background in finance and accounting.
• Mr. Lake's compensation includes an annual base salary of $470,000, eligibility for a 60% bonus of his base salary at the target level of achievement in 2025, and equity awards.
• He will receive a restricted stock unit (RSU) award for 262,500 shares and a performance stock unit (PSU) award for up to 750,000 shares, both vesting over time.
• Mr. Lake will also participate in the company's benefit plans and is entitled to five weeks of vacation per year, pro-rated for 2024.
• The company will reimburse Mr. Lake for reasonable out-of-pocket expenses related to his travel to the company's headquarters, up to $5,000 per month initially.
• The company has also issued a press release on August 29, 2024, announcing the CFO transition.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the appointment of an experienced CFO and the company's forward-looking statements. The transition is well-managed, and the new CFO's background is seen as a strong asset. There are no significant negative indicators.

Positives

• The appointment of Ryan Lake brings a seasoned financial executive with extensive experience in the CDMO industry.
• Mr. Lake has a proven track record of success in financial management, M&A, and capital raising.
• The compensation package, including equity awards, is designed to incentivize Mr. Lake's performance and align his interests with the company's success.
• The company is providing a generous reimbursement package for Mr. Lake's travel expenses.
• The transition is well-planned with a clear succession plan in place.

Negatives

• The departure of John Morberg, the current CFO, may create a temporary disruption in the company's financial operations.
• The company will incur costs associated with the severance package for Mr. Morberg.
• The vesting of the PSU awards is dependent on the company's stock price performance, which may not be guaranteed.

Risks

• The company's ability to successfully integrate Mr. Lake into the organization and ensure a smooth transition is crucial.
• The company's stock price performance may not reach the targets required for the PSU awards to fully vest.
• The company's financial performance may be impacted by the departure of the current CFO.
• There is a risk that the company may not be able to achieve its growth targets.

Future Outlook

The company is working to refine and execute a comprehensive strategy to marry its unique strengths with the significant opportunities in the CDMO space in order to achieve sustained growth. The company believes that Ryan Lake's experience will be instrumental in steering Lifecore toward its next chapter of growth.

Management Comments

• Paul Josephs, president and chief executive officer of Lifecore, expressed gratitude to John Morberg for his service and contributions to the company.
• Mr. Josephs stated that Ryan Lake's experience uniquely positions him for the CFO role.
• Mr. Josephs believes that Mr. Lake's skills in investor relations and financial strategy will be instrumental in steering Lifecore toward its next chapter of growth.
• Mr. Josephs highlighted the company's commitment to transparency and value creation.

Industry Context

The appointment of Ryan Lake, a seasoned CDMO financial executive, aligns with the industry trend of companies seeking experienced leaders to navigate the complexities of the contract development and manufacturing space. His experience in mergers, acquisitions, and spin-offs is particularly relevant as the CDMO industry continues to consolidate and evolve.

Comparison to Industry Standards

• Ryan Lake's previous role as CFO of Societal CDMO, a publicly traded company, provides a benchmark for his experience and capabilities.
• His involvement in the sale of Societal CDMO to CoreRx is comparable to other M&A transactions in the CDMO sector.
• The compensation package offered to Mr. Lake, including base salary, bonus potential, and equity awards, is consistent with industry standards for CFOs in publicly traded companies.
• The vesting schedule for the RSU and PSU awards is also typical for executive compensation packages.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of a new CFO with extensive industry experience positively.
• Employees may experience a change in leadership within the finance department.
• Customers and suppliers may not be directly impacted by this change.
• Creditors may view the appointment of an experienced CFO as a positive sign of financial stability.

Next Steps

• Ryan Lake will officially begin his role as CFO on September 3, 2024.
• The company will finalize the terms of the equity awards and provide the award agreements to Mr. Lake.
• Mr. Lake will work remotely and spend approximately one week a month at the company's headquarters.
• The company will continue to execute its strategic plan and work towards achieving its growth targets.

Key Dates

Keywords

Chief Financial Officer, CFO, Ryan Lake, John Morberg, Lifecore Biomedical, CDMO, Executive Appointment, Equity Awards, Financial Executive, Severance, Restricted Stock Units, Performance Stock Units